This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) slid 2.85% to $7.15 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.77% to 4,458.58 and Dow Jones Industrial Average falling 0.78% to 34,607.72. Ocugen Inc. closed $11.62 short of its 52-week high ($18.77), which the company achieved on February 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Adverum Biotechnologies Inc. (ADVM) fell 4.27% to $2.24, Ocular Therapeutix Inc. (OCUL) fell 3.38% to $10.87, and Kodiak Sciences Inc. (KOD) fell 1.10% to $96.39. Trading volume (4.1 M) remained 9.4 million below its 50-day average volume of 13.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 10, 2021.
(END) Dow Jones Newswires
September 10, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.